S. Reed - May 24, 2022 Form 3 Insider Report for Adamis Pharmaceuticals Corp (ADMP)

Role
Director
Signature
/s/ David C. Benedicto, as Attorney-in-Fact
Stock symbol
ADMP
Transactions as of
May 24, 2022
Transactions value $
$0
Form type
3
Date filed
5/26/2022, 04:28 PM
Previous filing
Apr 28, 2022
Next filing
May 11, 2023

No securities are beneficially owned.